As a result, your blood sugar levels may change, and you may not experience the same benefits in managing your diabetes
Researchers are also evaluating retatrutide for type 2 diabetes (TRIUMPH-2), cardiovascular outcomes (TRIUMPH-3), and other conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD)
Coker T.R., Gottschlich E.A., Burr W.H., Lipkin P.H
Understanding available options helps patients prioritize treatments based on their specific concerns and goals
Martnez, Josep Costa, Josep Quer, Javier Prez-Garreta, Alejandra Gonzlez-Snchez, Andrs Antn, Toms Pumarola, International Journal of Molecular Sciences .2024
Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC et al